Who are Sana Biotechnology, Inc.'s main suppliers?

Sana Biotechnology, Inc. (SANA) key suppliers include: TD-SECURITIES-USA-LLC, Beam Therapeutics Inc., Beam Therapeutics Inc., Myriad Genetics, Inc., Myriad Genetics, Inc. and 2 more. View the full supplier network at chainsifter.com/chain/SANA.

Who are Sana Biotechnology, Inc.'s major customers?

Sana Biotechnology, Inc. (SANA) key customers include: MAYO-CLINIC, Beam Therapeutics Inc., Beam Therapeutics Inc., Myriad Genetics, Inc., Myriad Genetics, Inc. and 2 more. View the full customer network at chainsifter.com/chain/SANA.

What sector is Sana Biotechnology, Inc. in?

Sana Biotechnology, Inc. (SANA) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

SANA Supply Chain: Sana Biotechnology, Inc. Supplier List & 16 Relationships

7Suppliers

7Customers

2Debt Items

20Related Chains

Sana Biotechnology, Inc. Suppliers

Ticker	Name	Confidence	Evidence
TD-SECURITIES-USA-LLC	TD-SECURITIES-USA-LLC	90%	In March 2026, the Company entered into an amended and restated sales agreement with TD Securities (USA) LLC (TD Cowen), acting as sales agent, pursuant to which the Company may offer and sell throug…
BEAM	Beam Therapeutics Inc.	72%	Reciprocal relationship from BEAM graph: Reciprocal relationship from SANA graph: Reciprocal relationship from BEAM graph: Reciprocal relationship from SANA graph: the University of California (UCSF)…
BEAM	Beam Therapeutics Inc.	72%	the University of California (UCSF), our fusogen technology that we acquired from Cobalt Biomedicine, Inc. (Cobalt), and gene editing technology that we licensed from Beam Therapeutics Inc., among ot…
MYGN	Myriad Genetics, Inc.	72%	with or controlled by state actors. If any theft or intrusion affects our technology, data, or intellectual property, the value of such technology, data, or intellectual property to our company may b…
MYGN	Myriad Genetics, Inc.	72%	Reciprocal relationship from MYGN graph: Reciprocal relationship from SANA graph: Reciprocal relationship from MYGN graph: Reciprocal relationship from SANA graph: Reciprocal relationship from MYGN g…
SNYNF	Sanofi	72%	with or controlled by state actors. If any theft or intrusion affects our technology, data, or intellectual property, the value of such technology, data, or intellectual property to our company may b…
SNYNF	Sanofi	72%	Reciprocal relationship from SNYNF graph: Reciprocal relationship from SANA graph: with or controlled by state actors. If any theft or intrusion affects our technology, data, or intellectual property…

Sana Biotechnology, Inc. Customers

Ticker	Name	Confidence	Evidence
MAYO-CLINIC	MAYO-CLINIC	92%	The Company agreed to sell to Mayo Clinic, and Mayo Clinic agreed to purchase from the Company, (i) 7,507,507 shares (the "Initial Shares") of the Company's common stock, $0.0001 par value per share …
BEAM	Beam Therapeutics Inc.	72%	the University of California (UCSF), our fusogen technology that we acquired from Cobalt Biomedicine, Inc. (Cobalt), and gene editing technology that we licensed from Beam Therapeutics Inc., among ot…
BEAM	Beam Therapeutics Inc.	72%	Reciprocal relationship from BEAM graph: Reciprocal relationship from SANA graph: the University of California (UCSF), our fusogen technology that we acquired from Cobalt Biomedicine, Inc. (Cobalt), …
MYGN	Myriad Genetics, Inc.	72%	Reciprocal relationship from MYGN graph: Reciprocal relationship from SANA graph: with or controlled by state actors. If any theft or intrusion affects our technology, data, or intellectual property,…
MYGN	Myriad Genetics, Inc.	72%	with or controlled by state actors. If any theft or intrusion affects our technology, data, or intellectual property, the value of such technology, data, or intellectual property to our company may b…
SNYNF	Sanofi	72%	with or controlled by state actors. If any theft or intrusion affects our technology, data, or intellectual property, the value of such technology, data, or intellectual property to our company may b…
SNYNF	Sanofi	72%	Reciprocal relationship from SNYNF graph: Reciprocal relationship from SANA graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from SANA graph: with or controlled by state actor…

Sana Biotechnology, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
SANA-DEBT	Debt stack $82.6M	90%	Market cache reports total debt of $82.6M.
SANA-DEBT-12365	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2021-12-31.

Sana Biotechnology, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Sana Biotechnology, Inc..

Sana Biotechnology, Inc. Ownership

Holder	Name	Confidence	Evidence
SANA-OWNER-FMR-LLC	FMR LLC	90%	13F overlay lists FMR LLC as top holder; 201 tracked holders.

Sana Biotechnology, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops
DBVTF	DBV TECHNOLOGIES	100.00	2
BNTC	Benitec Biopharma Inc.	100.00	2
BLRX	BioLineRx Ltd.	100.00	2
CTMX	CytomX Therapeutics, Inc.	100.00	2
ALXO	ALX Oncology Holdings Inc.	100.00	2
ATOS	Atossa Therapeutics, Inc.	100.00	2
WHWK	Whitehawk Therapeutics, Inc.	100.00	2
CYTOF	Altamira Therapeutics Ltd.	100.00	2
BIOA	BioAge Labs, Inc.	100.00	2
CYTK	Cytokinetics, Incorporated	100.00	2
ANL	Adlai Nortye Ltd.	100.00	2
CBIO	Crescent Biopharma, Inc.	100.00	2
ANRO	Alto Neuroscience, Inc.	100.00	2
EDIT	Editas Medicine, Inc.	100.00	2
BNBX	BNB Plus Corp.	100.00	2
CCEP	Coca-Cola Europacific Partners PLC	100.00	2
DSGN	Design Therapeutics, Inc.	100.00	2
PSNL	Personalis, Inc.	100.00	2
AZN	AstraZeneca PLC	100.00	2
REGN	Regeneron Pharmaceuticals, Inc.	100.00	2

Sana Biotechnology, Inc. Supply Chain